[BECAIT [Bezafibrate Coronary Atherosclerosis Intervention Trial]].
Yoshino
G
G
Department of Laboratory Medicine, Toho University School of Medicine.
Hirano
T
T
Kazumi
T
T
D001629:Bezafibrate / Q000627:therapeutic use*; D008076:Cholesterol, HDL / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D005340:Fibrinogen; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D016032:Randomized Controlled Trials as Topic; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D014280:Triglycerides; D005340:Fibrinogen; D001629:Bezafibrate